Medi Pharma’s product contains 2.5 mg of letrozole, an effective aromatase inhibitor that lowers estrogen levels and is therefore ideal for bodybuilders during post-cycle therapy (PCT).
Letromed 2.5 from Medi Pharma contains 2.5 mg of letrozole, a potent aromatase inhibitor designed to lower estrogen production in the body. This compound is essential for bodybuilders who want to mitigate estrogen-related side effects that can occur when using anabolic steroids. By effectively lowering estrogen levels, Letromed 2.5 promotes a more favorable testosterone-to-estrogen ratio, which can improve muscle retention and overall body composition. It is particularly useful during post-cycle therapy (PCT) as it helps restore hormonal balance and support optimal recovery after a cycle. With Letromed 2.5, athletes can effectively manage their estrogen levels, allowing them to maintain their hard-earned progress and achieve their fitness goals.
Reviews
There are no reviews yet.